Identification of SNP rs1799854 ABCC8 gene and blood glucose levels in patients with type 2 diabetes mellitus at Moewardi hospital Surakarta Solo

Authors

  • Mardiana Puji Lestari Program pasca Sarjana Farmasi klinik, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Imaniar Noor Faridah Fakultas Farmasi Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Rita Maliza Program Studi Biologi, Fakultas Sains dan Teknologi Terapan Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Melinda Widianingrum Program Studi Biologi, Fakultas Sains dan Teknologi Terapan Universitas Ahmad Dahlan, Yogyakarta, Indonesia
  • Dyah Aryani Perwitasari Program pasca Sarjana Farmasi klinik, Fakultas Farmasi, Universitas Ahmad Dahlan, Yogyakarta, Indonesia

DOI:

https://doi.org/10.12928/pharmaciana.v11i3.19100

Keywords:

T2DM, Sulfonylurea, ABCC8, Outcome therapy

Abstract

Type 2 diabetes mellitus (T2DM) is a complex metabolic disease characterized by high blood glucose levels due to impaired insulin secretion or insulin resistance. Polymorphisms in the ABCC8 gene rs1799854 are widely found to have an association with T2DM, where the ABCC8 gene encodes the SUR1 protein from the K-ATP channel that plays a role in insulin secretion in cells β pancreas. Mutations in the ABCC8 gene can cause potassium channels and insulin secretions problems that possibly decrease the effectiveness of the drug. Polymorphisms in some populations have been reported, but similar research on Solo's population has never been conducted. The purpose of this study is to identify the genotype of the ABCC8 gene in rs1799854 and the therapeutic outcome of blood glucose levels in T2DM patients. This research is cross-sectional research conducted prospectively at Moewardi Hospital Surakarta, Solo. Blood samples were collected from 10 T2DM patients who received sulfonylurea monotherapy taken through veins for genotype examination by DNA isolation, PCR amplification, and sequencing. Parameters of fasting blood glucose (FBG), 2-hour postprandial blood glucose, and HbA1c are measured as therapeutic outcomes. We found the dominant results in a mutant homozygote (TT) 40%; while wild type (CC); and a mutant heterozygote (CT) was 30%. Single Nucleotide Polymorphisms (SNP) of ABCC8 gene rs1799854, found in T2DM patients at Moewardi Hospital Surakarta, Solo, who received sulfonylurea therapy.

References

ADA. (2020). Standars of medical care in diabetes 2020 ADA. American Diabetes Association, 43(479), 960–1010. https://doi.org/10.1192/bjp.111.479.1009-a

Al Mansour, M. A. (2020). The prevalence and risk factors of type 2 diabetes mellitus (DMT2) in a semi-urban Saudi population. International Journal of Environmental Research and Public Health, 17(1), 1–8. https://doi.org/10.3390/ijerph17010007

Anonim. (2021). ABCC8 Gene. https://www.genecards.org/cgi-bin/carddisp.pl?gene=ABCC8%0A25 maret 2021; 9.38 pm

Begic, E., Arnautovic, A., & Masic, and. (2016). Assessment of Risk Factors for Diabetes Mellitus Type 2. Materia Socio Medica, 28(3), 187. https://doi.org/10.5455/msm.2016.28.187-190

Chien, H. H., Chang, C. T., Chu, N. F., Hsieh, S. H., Huang, Y. Y., Lee, I. Te, Lee, W. J., Tang, Y. J., & Sheu, W. H. H. (2007). Effect of glyburide-metformin combination tablet in patients with type 2 diabetes. Journal of the Chinese Medical Association, 70(11), 473–480. https://doi.org/10.1016/S1726-4901(08)70044-3

Engwa, G. A., Nwalo, F. N., Chikezie, C. C., Onyia, C. O., Ojo, O. O., Mbacham, W. F., & Ubi, B. E. (2018). Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population. BMC Medical Genetics, 19(1), 1–7. https://doi.org/10.1186/s12881-018-0601-1

Firdaushty, R., Usman, E., & Linosefa, L. (2020). Gambaran polimorfisme gen SLC22A1 rs683369 pada pasien diabetes melitus tipe 2 yang mendapatkan terapi metformin. Jurnal Kesehatan Andalas, 9(1S), 88–93. https://doi.org/10.25077/jka.v9i1s.1160

Gumantara, M. P. B., & Oktarlina, R. Z. (2017). Perbandingan monoterapi dan kombinasi terapi sulfonilurea-metformin terhadap pasien diabetes melitus tipe 2. Majority, 6(1), 1–5

Haghverdizadeh, P., Sadat Haerian, M., Haghverdizadeh, P., & Sadat Haerian, B. (2014). ABCC8 genetic variants and risk of diabetes mellitus. Gene, 545(2), 198–204. https://doi.org/10.1016/j.gene.2014.04.040

Hu, M., Wan, Y., Yu, L., Yuan, J., Ma, Y., Hou, B., Jiang, X., & Shang, L. (2017). Prevalence, awareness and associated risk factors of diabetes among adults in Xi’an, China. Scientific Reports, 7(1), 1–9. https://doi.org/10.1038/s41598-017-10797-x

Januaristiningtyas, A. I. (2018). Trend dan prevalensi diabetes mellitus tipe 2 di kota Surakarta. Diabetic Research, 121

Kemenkes. (2018). Hari diabetes sedunia tahun 2018 definisi diabetes

Kemenkes RI. (2018). Laporan provinsi Jawa Tengah Riskesdas 2018. In Kementerian Kesehatan RI

Klen, J., Dolžan, V., & Janež, A. (2014). CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients. European Journal of Clinical Pharmacology, 70(4), 421–428. https://doi.org/10.1007/s00228-014-1641-x

Koren, S., & Koren, R. (2015). Any Polymorphisms of CYP2C9 Affects the Biochemical Profile of Diabetic Patients Receiving Glibenclamide. Clinical & Medical Biochemistry: Open Access, 01(01), 1–4. https://doi.org/10.4172/2471-2663.1000102

Ordelheide, A. M., Hrabě De Angelis, M., Häring, H. U., & Staiger, H. (2018). Pharmacogenetics of oral antidiabetic therapy. Pharmacogenomics, 19(6), 577–587. https://doi.org/10.2217/pgs-2017-0195

Qin, L. J., Lv, Y., & Huang, Q. Y. (2013). Meta-analysis of association of common variants in the KCNJ11-ABCC8 region with type 2 diabetes. Genetics and Molecular Research, 12(3), 2990–3002. https://doi.org/10.4238/2013.August.20.1

Riskesdas, K. (2018). Hasil utama riset kesehatan dasar (RISKESDAS). Journal of Physics A: Mathematical and Theoretical, 44(8), 1–200. https://doi.org/10.1088/1751-8113/44/8/085201

Sakamoto, Y., Inoue, H., Keshavarz, P., Miyawaki, K., Yamaguchi, Y., Moritani, M., Kunika, K., Nakamura, N., Yoshikawa, T., Yasui, N., Shiota, H., Tanahashi, T., & Itakura, M. (2007). SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. Journal of Human Genetics, 52(10), 781–793. https://doi.org/10.1007/s10038-007-0190-x

Venkatesan, R., Bodhini, D., Narayani, N., & Mohan, V. (2014). Association study of the ABCC8 gene variants with type 2 diabetes in south Indians. Indian Journal of Human Genetics, 20(1), 37–42. https://doi.org/10.4103/0971-6866.132752

Wiyatno, A., Artika, I. M., & Malik, S. G. (2011). Asosiasi polimorfisme gen kcnj11 dan abcc8 dengan diabetes mellitus tipe 2 pada populasi masyarakat bali ageng wiyatno. Pharmacogenetic Research

Yokoi, N., Kanamori, M., Horikawa, Y., Takeda, J., Sanke, T., Furuta, H., Nanjo, K., Mori, H., Kasuga, M., Hara, K., Kadowaki, T., Tanizawa, Y., Oka, Y., Iwami, Y., Ohgawara, H., Yamada, Y., Seino, Y., Yano, H., Cox, N. J., & Seino, S. (2006). Association studies of variants in the genes involved in pancreatic β-cell function in type 2 diabetes in Japanese subjects. Diabetes, 55(8), 2379–2386. https://doi.org/10.2337/db05-1203

Zhou, D., Zhang, D., Liu, Y., Zhao, T., Chen, Z., Liu, Z., Yu, L., Zhang, Z., Xu, H., & He, L. (2009). The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. Journal of Human Genetics, 54(7), 433–435. https://doi.org/10.1038/jhg.2009.54

Zhou, X., Chen, C., Yin, D., Zhao, F., Bao, Z., Zhao, Y., Wang, X., Li, W., Wang, T., Jin, Y., Lv, D., Lu, Q., & Yin, X. (2019). A variation in the ABCC8 gene is associated with type 2 diabetes mellitus and repaglinide efficacy in chinese type 2 diabetes mellitus patients. Internal Medicine, 58(16), 2341–2347. https://doi.org/10.2169/internalmedicine.2133-18

Downloads

Published

2021-10-23

Issue

Vol. 11 No. 3 (2021): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.